Skip to main navigation Skip to search Skip to main content

The evolving reduction of vancomycin and daptomycin susceptibility in mrsa—salvaging the gold standards with combination therapy

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Article number762
Pages (from-to)1-21
Number of pages21
JournalAntibiotics
Volume9
Issue number11
DOIs
StatePublished - Nov 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Microbiology
  • Biochemistry
  • General Pharmacology, Toxicology and Pharmaceutics
  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Keywords

  • Combination therapy
  • Daptomycin
  • MRSA
  • Vancomycin

Cite this